Avenue Therapeutics, Inc. (ATXI) stock
ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.43+0.00 (0.00%)
Close on Oct 16, 2026Market cap $1.42MP/E –Yield –
Earnings
Avenue Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2024
–
EPS, Q3 FY2024
-$1.92
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Avenue Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024during market hours | – | – | -$1.92 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 9, 2024during market hours | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 15, 2024before the open | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 18, 2024during market hours | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023during market hours | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023during market hours | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 12, 2023before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 30, 2023during market hours | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022during market hours | – | – | – | Release |
| Q2 FY2020ended Jun 30, 2020 | Aug 14, 2020before the open | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 11, 2020before the open | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 30, 2020before the open | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Nov 4, 2019before the open | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 14, 2019before the open | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | May 13, 2019before the open | – | – | – | Filing |
| Q4 FY2018ended Dec 31, 2018 | Mar 12, 2019before the open | – | – | – | Filing |
| Q3 FY2018ended Sep 30, 2018 | Nov 14, 2018during market hours | – | – | – | Filing |
| Q1 FY2018ended Mar 31, 2018 | May 3, 2018before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Avenue Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Avenue Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Avenue Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Results
- Results
- Results
- News
- News
- Results
- News
- Results
- News
- News
- Results
- Results
- News
See a number that looks wrong?